M M Rosu1, S G Popa2, E Mota3, A Popa4, M Manolache5, C Guja6, C Bala7, C Mota7, M Mota8,4. 1. Clinical County Emergency Hospital Craiova, Romania, Dept. of Diabetes, Nutrition and Metabolic Diseases, Craiova University of Medicine and Pharmcy, Romania. 2. Dept. of Diabetes, Nutrition and Metabolic Diseases, Romania. 3. Dept. of Nephrology, Romania. 4. Clinical Emergency Hospital, Department of Diabetes, Nutrition and Metabolic Diseases - Craiova, Romania. 5. CEBIS International SAGL Switzerland. 6. "N.C. Paulescu" National Institute of Diabetes, Nutrition and Metabolic Diseases - Bucharest, Romania. 7. "Iuliu Hatieganu" University of Medicine and Pharmacy - Diabetes, Nutrition and Metabolic Diseases - Cluj-Napoca, Romania. 8. Dept. of Diabetology, Romania.
Abstract
Atherosclerotic Cardiovascular Diseases are the leading cause of death worldwide. AIM: To estimate the prevalence of cardiovascular risk (CVR) categories in the adult population (aged 40-79 years) of Romania. DESIGN: The present study was part of the epidemiological, cross-sectional PREDATORR study (PREvalence of DiAbeTes mellitus, prediabetes, overweight, Obesity, dyslipidemia, hyperuricemia and chronic kidney disease in Romania). SUBJECTS AND METHODS: Exclusion criteria: age <40/or>79 years old and diagnosis of ischemic vascular disease. The CVR was evaluated using charts developed by the World Health Organization/ International Society of Hypertension (WHO/ISH) available for Europe B (epidemiological sub-region where Romania was included). The CVR was divided into 5 categories: <10%, 10-20%, 20-30%, 30-40%, > 40%. RESULTS: A total of 1631 subjects (57.0±10.7 years, 45.1% males) were included in the present study.The age and sex-adjusted prevalence of CVR >40% was 2.9% (95%CI 2.8-3.1%), CVR 30-40% was 1.85% (95%CI 1.8-1.9%), CVR 20-30% was 5.8% (95%CI 5.6-6.0%) and 13.0% (95%CI 12.8-13.3%) of the adult Romanian population has a 10-20% CVR, these CVR categories being more frequent in male and older age. Diabetes, overweight/obesity and smoking were associated with high CVR categories. CONCLUSION: Romania is one of the countries with high CVR, requiring CVD prevention measures.
Atherosclerotic Cardiovascular Diseases are the leading cause of death worldwide. AIM: To estimate the prevalence of cardiovascular risk (CVR) categories in the adult population (aged 40-79 years) of Romania. DESIGN: The present study was part of the epidemiological, cross-sectional PREDATORR study (PREvalence of DiAbeTes mellitus, prediabetes, overweight, Obesity, dyslipidemia, hyperuricemia and chronic kidney disease in Romania). SUBJECTS AND METHODS: Exclusion criteria: age <40/or>79 years old and diagnosis of ischemic vascular disease. The CVR was evaluated using charts developed by the World Health Organization/ International Society of Hypertension (WHO/ISH) available for Europe B (epidemiological sub-region where Romania was included). The CVR was divided into 5 categories: <10%, 10-20%, 20-30%, 30-40%, > 40%. RESULTS: A total of 1631 subjects (57.0±10.7 years, 45.1% males) were included in the present study.The age and sex-adjusted prevalence of CVR >40% was 2.9% (95%CI 2.8-3.1%), CVR 30-40% was 1.85% (95%CI 1.8-1.9%), CVR 20-30% was 5.8% (95%CI 5.6-6.0%) and 13.0% (95%CI 12.8-13.3%) of the adult Romanian population has a 10-20% CVR, these CVR categories being more frequent in male and older age. Diabetes, overweight/obesity and smoking were associated with high CVR categories. CONCLUSION: Romania is one of the countries with high CVR, requiring CVD prevention measures.
Entities:
Keywords:
Romanian population; WHO/ISH charts; cardovascular risk
Authors: Michael Pignone; Mark J Alberts; John A Colwell; Mary Cushman; Silvio E Inzucchi; Debabrata Mukherjee; Robert S Rosenson; Craig D Williams; Peter W Wilson; M Sue Kirkman Journal: J Am Coll Cardiol Date: 2010-06-22 Impact factor: 24.094
Authors: Maria Dorobanţu; Roxana Darabont; S Ghiorghe; K Babes; Dana Pop; Daciana Toma; Maria Vasilescu; Minodora Dobreanu; Oana Tăutu Journal: Rom J Intern Med Date: 2012 Oct-Dec
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel Journal: Circulation Date: 2008-01-22 Impact factor: 29.690
Authors: Shanthi Mendis; Lars H Lindholm; Giuseppe Mancia; Judith Whitworth; Michael Alderman; Stephen Lim; Tony Heagerty Journal: J Hypertens Date: 2007-08 Impact factor: 4.844
Authors: Marshall K Tulloch-Reid; Novie O Younger; Trevor S Ferguson; Damian K Francis; Abdullahi O Abdulkadri; Georgiana M Gordon-Strachan; Shelly R McFarlane; Colette A Cunningham-Myrie; Rainford J Wilks; Simon G Anderson Journal: PLoS One Date: 2013-06-21 Impact factor: 3.240
Authors: D C Protasiewicz Timofticiuc; I M Vladu; A G Stefan; M C Forțofoiu; A Mitrea; M Fortofoiu; M Mota Journal: Acta Endocrinol (Buchar) Date: 2022 Jan-Mar Impact factor: 1.104